Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1999 1
2000 1
2003 1
2007 1
2010 2
2011 2
2012 1
2017 4
2018 1
2019 3
2020 1
2021 2
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean wiktor a (137 results)?
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
Ostergaard L, Vesikari T, Absalon J, Beeslaar J, Ward BJ, Senders S, Eiden JJ, Jansen KU, Anderson AS, York LJ, Jones TR, Harris SL, O'Neill R, Radley D, Maansson R, Prégaldien JL, Ginis J, Staerke NB, Perez JL; B1971009 and B1971016 Trial Investigators. Ostergaard L, et al. N Engl J Med. 2017 Dec 14;377(24):2349-2362. doi: 10.1056/NEJMoa1614474. N Engl J Med. 2017. PMID: 29236639 Free article. Clinical Trial.
A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations.
Wysocki J, Center KJ, Brzostek J, Majda-Stanislawska E, Szymanski H, Szenborn L, Czajka H, Hasiec B, Dziduch J, Jackowska T, Witor A, Kopińska E, Konior R, Giardina PC, Sundaraiyer V, Patterson S, Gruber WC, Scott DA, Gurtman A. Wysocki J, et al. Among authors: witor a. Vaccine. 2017 Apr 4;35(15):1926-1935. doi: 10.1016/j.vaccine.2017.02.035. Epub 2017 Mar 3. Vaccine. 2017. PMID: 28262330 Free article. Clinical Trial.
Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland.
Parczewski M, Jabłonowska E, Wójcik-Cichy K, Zhyvytsia D, Witak-Jędra M, Leszczyszyn-Pynka M, Aksak-Wąs B, Siwak E, Cielniak I, Olczak A, Szymczak A, Szetela B, Bociąga-Jasik M, Kalinowska-Nowak A, Mularska E, Witor A, Jakubowski P, Hlebowicz M, Rozpłochowski B, Łojewski W, Scheibe K, Serwin K. Parczewski M, et al. Among authors: witor a. Clin Infect Dis. 2023 May 24;76(10):1708-1715. doi: 10.1093/cid/ciad116. Clin Infect Dis. 2023. PMID: 36888680
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.
Orkin C, Molina JM, Negredo E, Arribas JR, Gathe J, Eron JJ, Van Landuyt E, Lathouwers E, Hufkens V, Petrovic R, Vanveggel S, Opsomer M; EMERALD study group. Orkin C, et al. Lancet HIV. 2018 Jan;5(1):e23-e34. doi: 10.1016/S2352-3018(17)30179-0. Epub 2017 Oct 6. Lancet HIV. 2018. PMID: 28993180 Clinical Trial.
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019.
Serwin K, Urbańska A, Scheibe K, Witak-Jędra M, Jankowska M, Hlebowicz M, Bociąga-Jasik M, Kalinowska-Nowak A, Biała M, Ciepłucha H, Łojewski W, Olczak A, Jabłonowska E, Kowalczuk-Kot A, Rozpłochowski B, Witor A, Parczewski M. Serwin K, et al. Among authors: witor a. Sci Rep. 2021 Aug 16;11(1):16609. doi: 10.1038/s41598-021-96125-w. Sci Rep. 2021. PMID: 34400726 Free PMC article.
HCV resistance-associated substitutions following direct-acting antiviral therapy failure - Real-life data from Poland.
Parczewski M, Janczewska E, Pisula A, Dybowska D, Łojewski W, Witor A, Wawrzynowicz-Syczewska M, Socha Ł, Krygier R, Knysz B, Musialik J, Urbańska A, Scheibe K, Jaroszewicz J. Parczewski M, et al. Among authors: witor a. Infect Genet Evol. 2021 Sep;93:104949. doi: 10.1016/j.meegid.2021.104949. Epub 2021 Jun 1. Infect Genet Evol. 2021. PMID: 34087494
Phylodynamic evolution of HIV-1 A6 sub-subtype epidemics in Poland.
Serwin K, Scheibe K, Urbańska A, Aksak-Wąs B, Karasińska-Cieślak M, Ząbek P, Siwak E, Cielniak I, Jabłonowska E, Wójcik-Cichy K, Jakubowski P, Bociąga-Jasik M, Witor A, Szymczak A, Szetela B, Parczewski M. Serwin K, et al. Among authors: witor a. J Med Virol. 2024 Feb;96(2):e29482. doi: 10.1002/jmv.29482. J Med Virol. 2024. PMID: 38381668
Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine.
Gadzinowski J, Albrecht P, Hasiec B, Konior R, Dziduch J, Witor A, Mellelieu T, Tansey SP, Jones T, Sarkozy D, Emini EA, Gruber WC, Scott DA. Gadzinowski J, et al. Among authors: witor a. Vaccine. 2011 Apr 5;29(16):2947-55. doi: 10.1016/j.vaccine.2011.02.002. Epub 2011 Feb 16. Vaccine. 2011. PMID: 21335032 Clinical Trial.
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.
Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; 2001 Study Investigators. Richmond PC, et al. Lancet Infect Dis. 2012 Aug;12(8):597-607. doi: 10.1016/S1473-3099(12)70087-7. Epub 2012 May 7. Lancet Infect Dis. 2012. PMID: 22569484 Clinical Trial.
24 results